Study of severe infections from drug-resistant bacteria
Part of Infections clinical trials.
This study looks at severe infections caused by bacteria that are resistant to common antibiotics. It tests how well newer antibiotics work for treating these infections in adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a severe infection (like pneumonia, urinary tract, abdominal, spine, or bloodstream infection).
- The infection is caused by a resistant type of bacteria (CRE).
- You have received at least one dose of one of these antibiotics: ceftazidime-avibactam, meropenem-vaborbactam, or cefiderocol.
- You agree to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called colistimethate sodium for people in the hospital with a serious infection (pneumonia or bloodstream infection) caused by a resistant bacteria called CRE. The goal is to see if this antibiotic can effectively treat the infection.
This study tests a precise dosing approach for the antibiotic ceftazidime-avibactam to treat serious infections in ICU patients. It aims to help people with hard-to-treat bacteria that are resistant to many other antibiotics.
This trial tests whether a treatment called fecal microbiota transplantation (giving you a capsule of healthy bacteria from a donor) can help clear a hard-to-treat bacteria called CRE from your body. It may help prevent future infections and reduce the need for strong antibiotics.
This study looks at the genetic diversity of a specific type of antibiotic-resistant E. coli bacteria found in southern France. It does not involve any new treatments for patients and only uses existing bacterial samples.
This trial looks at how well two antibiotics, ceftazidime-avibactam and fosfomycin, work together to treat infections caused by highly resistant bacteria called CRE. It may help find the best way to use these medicines.
This study checks if a special test (Xpert Carba-R) can find a type of drug-resistant bacteria, called CRE, in fluid from the lungs and in rectal swabs. It might help doctors treat lower respiratory tract infections more effectively.
Hear when a new Carbapenem-Resistant Enterobacteriaceae Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.